{"nct_id":"NCT04313244","title":"Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 Years","status":"COMPLETED","status_verified_date":"2024-01","start_date":"2021-05-15","start_date_type":"ACTUAL","primary_completion_date":"2022-02-21","primary_completion_date_type":"ACTUAL","completion_date":"2022-07-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TAK"]}